The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it’s still inside a patient’s body. In exclusive interviews, NPR talks with two of the first participants.
Blind Patients Hope Landmark Gene-Editing Experiment Will Restore Their Vision
Posted in biotech/medical, genetics